[go: up one dir, main page]

HRP20000736A2 - Human bmp-7 promotor and method for exploring bone-related substance by using the same - Google Patents

Human bmp-7 promotor and method for exploring bone-related substance by using the same Download PDF

Info

Publication number
HRP20000736A2
HRP20000736A2 HR20000736A HRP20000736A HRP20000736A2 HR P20000736 A2 HRP20000736 A2 HR P20000736A2 HR 20000736 A HR20000736 A HR 20000736A HR P20000736 A HRP20000736 A HR P20000736A HR P20000736 A2 HRP20000736 A2 HR P20000736A2
Authority
HR
Croatia
Prior art keywords
bone
substances
vector
human
seq
Prior art date
Application number
HR20000736A
Other languages
English (en)
Croatian (hr)
Inventor
Shinji Kawai
Takeyuki Sugiura
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of HRP20000736A2 publication Critical patent/HRP20000736A2/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HR20000736A 1998-04-30 1999-04-22 Human bmp-7 promotor and method for exploring bone-related substance by using the same HRP20000736A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10120174A JPH11313675A (ja) 1998-04-30 1998-04-30 ヒトｂｍｐ−７プロモーターおよびこれを用いた骨関連物質の探索法
PCT/IB1999/000733 WO1999057293A1 (en) 1998-04-30 1999-04-22 Human bmp-7 promoter and method for exploring bone-related substance by using the same

Publications (1)

Publication Number Publication Date
HRP20000736A2 true HRP20000736A2 (en) 2001-10-31

Family

ID=14779761

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20000736A HRP20000736A2 (en) 1998-04-30 1999-04-22 Human bmp-7 promotor and method for exploring bone-related substance by using the same

Country Status (26)

Country Link
US (2) US6534268B1 (sk)
EP (1) EP1076713A1 (sk)
JP (1) JPH11313675A (sk)
KR (1) KR20010071193A (sk)
CN (1) CN1170941C (sk)
AP (1) AP1329A (sk)
AU (1) AU769124B2 (sk)
BG (1) BG64780B1 (sk)
BR (1) BR9910585A (sk)
CA (1) CA2326957A1 (sk)
EA (1) EA004509B1 (sk)
EE (1) EE200000627A (sk)
GE (1) GEP20033056B (sk)
HR (1) HRP20000736A2 (sk)
HU (1) HUP0102329A3 (sk)
ID (1) ID26704A (sk)
IL (1) IL139100A0 (sk)
NO (1) NO20005433D0 (sk)
NZ (1) NZ507625A (sk)
PL (1) PL343817A1 (sk)
SK (1) SK16082000A3 (sk)
TR (1) TR200003182T2 (sk)
UA (1) UA72212C2 (sk)
WO (1) WO1999057293A1 (sk)
YU (1) YU64900A (sk)
ZA (1) ZA200006080B (sk)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003300076C1 (en) 2002-12-30 2010-03-04 Angiotech International Ag Drug delivery from rapid gelling polymer composition
US20070015701A1 (en) * 2005-06-01 2007-01-18 Samuel Zalipsky Macromolecular conjugates of bone morphogenetic protein-7
SI2078073T1 (sl) * 2006-10-12 2013-11-29 Ethicon, Inc. Celice, pridobljene iz ledvice, in postopki uporabe pri popravljanju tkiv in regeneraciji
EP2293808B1 (en) * 2008-05-16 2012-08-15 Industry Foundation Of Chonnam National University An synthetic peptide containing bone forming peptide 1(bfp 1) for stimulating osteoblast differentiation, and pharmaceutical composition comprising the synthetic peptide
KR20130110143A (ko) 2010-06-09 2013-10-08 셈프러스 바이오사이언시스 코퍼레이션 방오성, 항균성, 항혈전성 그라프트-프롬 조성물
EP2579906A4 (en) 2010-06-09 2016-03-23 Arrow Int Inc ARTICLES HAVING NON-CLASSING SURFACES AND METHODS FOR PREPARING THEM WITHOUT ALTERING GENERAL PHYSICAL PROPERTIES
US20110305898A1 (en) 2010-06-09 2011-12-15 Zheng Zhang Non-fouling, anti-microbial, anti-thrombogenic graft compositions
US9511071B2 (en) 2010-08-18 2016-12-06 Emory University Compounds and compositions for ossification and methods related thereto
US9295754B2 (en) 2011-02-24 2016-03-29 Emory University Noggin inhibitory compositions for ossification and methods related thereto
CA2826773C (en) 2011-02-24 2019-07-16 Emory University Jab1 blocking compositions for ossification and methods related thereto
MX2014007211A (es) 2011-12-14 2015-04-14 Semprus Biosciences Corp Lente de contacto de hidrogel de silicona modificada usando oxidantes de lantanido o de metal de transicion.
MX2014007202A (es) 2011-12-14 2015-03-09 Semprus Biosciences Corp Lentes de contacto modificadas en la superficie.
EP2791214A4 (en) 2011-12-14 2015-11-04 Semprus Biosciences Corp REDOX PROCESS FOR CONTACT LENS MODIFICATION
MX2014007203A (es) 2011-12-14 2015-04-14 Semprus Biosciences Corp Proceso de imbibicion para modificacion de superficie de lente de contacto.
WO2013090801A1 (en) 2011-12-14 2013-06-20 Semprus Biosciences Corp. Multistep uv process to create surface modified contact lenses
WO2019005563A1 (en) * 2017-06-27 2019-01-03 St. Jude Children's Research Hospital METHODS ASSOCIATED WITH THE ACTIVATION OF THE SIGNALING PATHWAY OF BONE MORPHOGENETIC PROTEINS

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266683A (en) 1988-04-08 1993-11-30 Stryker Corporation Osteogenic proteins
ES2113857T3 (es) * 1989-03-28 1998-05-16 Genetics Inst Composiciones osteoinductoras.
US5650276A (en) * 1991-03-11 1997-07-22 Creative Biomolecules, Inc. Morphogenic protein screening method
WO1993003382A2 (en) * 1991-08-01 1993-02-18 Pharmaceutical Discovery Corporation Characterization of specific drug receptors with fluorescent ligands
EP0804573A1 (en) * 1994-06-07 1997-11-05 Creative Biomolecules, Inc. Methods and compositions for modulating morphogenic protein expression
US6083690A (en) 1995-06-02 2000-07-04 Osteoscreen, Inc. Methods and compositions for identifying osteogenic agents
BR9713130A (pt) 1996-11-22 2000-02-08 Akzo Nobel Nv Região promotora de bmp-4 e seus fragmentos, vetor compreendendo uma região promotora de bmp-4 ou seus fragmentos, célula hospedeira, processo para a identificação de agentes terapêuticos para a prevenção e/ou tratamento da osteoporose, e, uso de ici 164384.
US5863790A (en) 1997-05-14 1999-01-26 Minnesota Mining And Manfacturing Company Biological sterility indicator
JP2001517092A (ja) * 1997-05-29 2001-10-02 クリエイティブ バイオモレキュールズ，インコーポレイテッド モルフォゲン発現のモジュレーターおよびモジュレーターを同定する方法

Also Published As

Publication number Publication date
JPH11313675A (ja) 1999-11-16
BR9910585A (pt) 2001-01-09
YU64900A (sh) 2003-10-31
ID26704A (id) 2001-02-01
CN1170941C (zh) 2004-10-13
SK16082000A3 (sk) 2001-05-10
NO20005433L (no) 2000-10-27
IL139100A0 (en) 2001-11-25
NZ507625A (en) 2003-12-19
WO1999057293A1 (en) 1999-11-11
AU769124B2 (en) 2004-01-15
AP1329A (en) 2004-11-22
EA200001130A1 (ru) 2001-04-23
EE200000627A (et) 2002-02-15
PL343817A1 (en) 2001-09-10
ZA200006080B (en) 2001-10-29
HUP0102329A3 (en) 2006-03-28
US6534268B1 (en) 2003-03-18
BG104883A (en) 2001-05-31
AP2000001982A0 (en) 2000-12-31
BG64780B1 (bg) 2006-03-31
GEP20033056B (en) 2003-08-25
EA004509B1 (ru) 2004-04-29
EP1076713A1 (en) 2001-02-21
TR200003182T2 (tr) 2001-02-21
CA2326957A1 (en) 1999-11-11
US20030040007A1 (en) 2003-02-27
KR20010071193A (ko) 2001-07-28
CN1307643A (zh) 2001-08-08
NO20005433D0 (no) 2000-10-27
HUP0102329A2 (hu) 2001-10-28
AU3163499A (en) 1999-11-23
UA72212C2 (en) 2005-02-15

Similar Documents

Publication Publication Date Title
HRP20000736A2 (en) Human bmp-7 promotor and method for exploring bone-related substance by using the same
Thompson et al. Structure of the gene encoding peripherin, an NGF-regulated neuronal-specific type III intermediate filament protein
Benkhelifa et al. mafA, a novel member of the maf proto-oncogene family, displays developmental regulation and mitogenic capacity in avian neuroretina cells
Geller et al. Molecular analysis of neuronal physiology by gene transfer into neurons with herpes simplex virus vectors
CA2214439C (en) A novel growth factor and a genetic sequence encoding same
Mackem et al. Ghox 4. 7: a chick homeobox gene expressed primarily in limb buds with limb-type differences in expression
Zhu et al. TNF-alpha represses transcription of human Bone Morphogenetic Protein-4 in lung epithelial cells
US6475735B1 (en) Human BMP-2 promoter and method for exploring bone-related substance by using the same
HRP20000735A2 (en) Human bmp-4 promotor and method for exploring bone-related substance by using the same
Hakki et al. Bone sialoprotein gene transfer to periodontal ligament cells may not be sufficient to promote mineralization in vitro or in vivo
JP2000004882A (ja) ヒトｍｐ５２遺伝子プロモーターおよびこれを用いた有用物質の探索法
US10835620B2 (en) Methods for treating heart failure using beta-ARKnt peptide
MXPA00010405A (en) Human bmp-4 promoter and method for exploring bone-related substance by using the same
CZ20004016A3 (cs) Lidský BMP-4 promotor a způsob pro výzkum substancí ovlivňujících kosti za použití tohoto promotoru
Laskowski Axon regeneration following peripheral nerve lesion is driven by cofilin mediated actin turnover
El-Hoss Inactivation of the Integrin-Linked Kinase in osteoblasts increases mineralization
WO1998048830A1 (en) Method for promoting myogenesis using osteogenic proteins
Coombs Behavioral Consequences Following AAV Mediated Hippocampal EAAC1 Knockdown
US20020019027A1 (en) Novel growth factor and a genetic sequence encoding same

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
PNAN Change of the applicant name, address/residence

Owner name: AVENTIS PHARMA S.A., FR

ODRP Renewal fee for the maintenance of a patent

Payment date: 20060316

Year of fee payment: 8

OBST Application withdrawn